Back

Circulating fibroblast growth factor 21 is associated with diastolic dysfunction in patients with preserved ejection fraction

28 August 2016 (16:48 - 16:57)
Organised by:
Congress Presentation Part of: Biomarkers made easy Diastolic dysfunction ESC Premium Access ESC Congress 2016

About the speaker

Photo
Doctor Ruey-Hsing Chou

Taipei Veterans General Hospital, Taipei (Taiwan)

9 More presentations in this session

Presentation thumbnail
Prognostic Utility of GDF-15 in Chronic Heart Failure: Insights From the HF-ACTION Study
Doctor A. Sharma (Durham, US)
Abstract Slides Video
Presentation thumbnail
Circulating miR-122-5p and miR-124a-3p predict outcome in out-of-hospital cardiac arrest patients.
Mr A. Salgado Somoza (Luxembourg, LU)
Abstract
Presentation thumbnail
Biomarkers in heart failure and adiposity results from the Gutenberg health study and validation in FINRISK
Doctor C. Sinning (Hamburg, DE)
Abstract Slides Video
Presentation thumbnail
A multi-time-point based multimarker risk stratification strategy in acute heart failure - results from the RELAX-AHF trial
Doctor B. Demissei (Groningen, NL)
Abstract Slides Video
Presentation thumbnail
Prediction of recurrent hospitalizations in heart failure using a multi-biomarker panel
Doctor A. Bayes Genis (Badalona, ES)
Abstract

Access the full session

Session thumbnail
Biomarkers made easy

The Event

Event poster

ESC Congress 2016

28 August 2016 16:48 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources